跳至主要内容
临床试验/NCT05786378
NCT05786378尚未招募2 期

Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.

Assiut University1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2023年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
23
试验地点
1
主要终点
Changes in Pure Tone Averages

研究概览

简要总结

Assessment of the efficacy of Intratympanic platelet rich plasma injection for treatment of idiopathic suden sensorineural hearing loss

详细描述

Sensorineural hearing loss is the collective term for hearing damage to the cochlea and auditory nerve and is by far the most common type of hearing loss in adults, accounting for over 90% of all cases. Sensorineural hearing loss is a heterogeneous disorder, which can arise due to damage to pathway for sound impulses from the hair cells of inner ear to auditory nerve and less commonly brain.

Sensorineural hearing loss is a challenge to physicians, as it progresses with age and causes significant reductions in quality of life and there are no treatments to reverse its effects, other than sound amplification with the use of hearing aids or direct auditory nerve stimulation via cochlear implantation.

Platelet-rich Plasma (PRP) Therapy is a cutting-edge procedure that is revolutionizing the hearing loss and deafness. Intratympanic instillation of Platelet-rich Plasma (PRP) does wonder to the hair cells of inner ear, thus improving the hearing.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients have sudden idiopathic sensorineural hearing loss

排除标准

  • •patients has previous ear surgery.
  • •patients has absent cochlea in CT or MRI
  • •patients has Cancer,Chronic liver disease, Hemodynamic instability,Hypofibrinogenemia, Platelet dysfunction syndromes, Systemic disorder, sepsis, Low platelet count.

研究组 & 干预措施

platlet rich plasma

Experimental

干预措施: Platelet Rich Plasma (Biological)

platlet rich plasma

Experimental

干预措施: local anesthesia in external auditory canal (Drug)

platlet rich plasma

Experimental

干预措施: Intratympanic Injection (Procedure)

结局指标

主要结局

Changes in Pure Tone Averages

时间窗: 6 weeks

Continuous pure tone averages calculated from pure tone audiometry will be summarized using the mean, standard deviation, median, 25th percentile, 75th percentile, minimum and maximum.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahmoud Hassan Ali

Resident doctor at Otolaryngology Departement, Principal Investigator

Assiut University

研究点 (1)

Loading locations...

相似试验